Withanolides: Promising candidates for cancer therapy
Phytotherapy Research · 2024-02 · 38 (2) · 1104-1158
DOI: 10.1002/ptr.8090 ↗At a glance
Übersichtsarbeit in Phytotherapy Research, published online on 2024-01-04. Written by Qiang Zhang and 4 co-authors. Institution: School of Medical Technology, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China. Major MEDLINE topics: Withanolides, Antineoplastic Agents, Neoplasms, Withania. Cited 34 times so far (Crossref); 324 references. Funded by: National Natural Science Foundation of China.
Abstract (original language)
Natural products have played a significant role throughout history in the prevention and treatment of numerous diseases, particularly cancers. As a natural product primarily derived from various medicinal plants in the Withania genus, withanolides have been shown in several studies to exhibit potential activities in cancer treatment. Consequently, understanding the molecular mechanism of withanolides could herald the discovery of new anticancer agents. Withanolides have been studied widely, especially in the last 20 years, and attracted the attention of numerous researchers. Currently, over 1200 withanolides have been classified, with approximately a quarter of them having been reported in the literature to be able to modulate the survival and death of cancer cells through multiple avenues. To what extent, though, has the anticancer effects of these compounds been studied? How far are they from being developed into clinical drugs? What are their potential, characteristic features, and challenges? In this review, we elaborate on the current knowledge of natural compounds belonging to this class and provide an overview of their natural sources, anticancer activity, mechanism of action, molecular targets, and implications for anticancer drug research. In addition, direct targets and clinical research to guide the design and implementation of future preclinical and clinical studies to accelerate the application of withanolides have been highlighted.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- School of Medical Technology, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China.
- State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China.
- Tianjin Key Laboratory of Therapeutic Substance of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China.
- School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China.
ORCID profiles: Qiang Zhang, YongKang Yuan, Shijie Cao, Ning Kang, Feng Qiu
Funding
- National Natural Science Foundation of China
Cite
APA
Zhang, Q., Yuan, Y., Cao, S., Kang, N., & Qiu, F. (2024). Withanolides: Promising candidates for cancer therapy. Phytotherapy Research, 38(2), 1104-1158. https://doi.org/10.1002/ptr.8090
Vancouver
Zhang Q, Yuan Y, Cao S, Kang N, Qiu F. Withanolides: Promising candidates for cancer therapy. Phytotherapy Research. 2024;38(2):1104-1158. doi:10.1002/ptr.8090
BibTeX
@article{Zhang2024,
author = {Zhang, Qiang and Yuan, YongKang and Cao, Shijie and Kang, Ning and Qiu, Feng},
title = {Withanolides: Promising candidates for cancer therapy},
journal = {Phytotherapy Research},
year = {2024},
volume = {38},
number = {2},
pages = {1104--1158},
doi = {10.1002/ptr.8090}
}
EUVIMED